Global Health Research: South-South collaboration is as equally important as North-South collaboration 

Global Health Research: South-South collaboration is as equally important as North-South collaboration 

Dr. Salako

 

By Morenike Oluwatoyin Folayan

The Director General of Nigerian Institute of Medical Research (NIMR), Professor Babatunde Salako, has explained and reiterated why south-south collaborations need to be pursued if the aims of global health is to be achieved.

This was during his talk at the 2018 Global Health Network conference which held on the 30th and 31st of January 2018 at the Sickle Cell Centre, Idi-Araba, Lagos.

He noted that global health involves collaboration that prioritises equity in health for all people. For him, food (in)security, trade in health damaging products (tobacco, arms, toxic waste), governance, war and conflict are some of the issues global health should address.

He noted that south-south collaboration is an evolving practice but has been largely limited by the invisibility of expertise/excellence in developing nations. South–South research collaboration could slow however, down the current pace of exodus of talented scientists and researchers from the South to the North.

Some potential areas of South -South collaboration includes interfaculty/ inter-institutional collaborations, networking (conferences), mentorship and training in new technologies.

Dr. Elima Jedy-Agba noted that at the Institute of Human Virology Nigeria, efforts have been made to leverage on their North-South collaborations to try to promote South -South collaborations.

One of such efforts, according to her, has been through setting up a world-class laboratory that can do genomic analysis and molecular biology. She identified significant benefits in many of the south-south collaborations they have tried to promote.

Dr Gbenga Ogunfowokan reiterated that actions need to be taken to encourage more South-South collaborations. At the Global Health Trials Network, platforms were created to promote south-south collaborations. Private sector engagement in research can also help facilitate such collaboration.

Ms Olayide Akanni who facilitated the session, asked for further considerations for West Africa where such South -South collaborations could be most beneficial.

This will require bridging the language barrier.  But concerted efforts are required to politically commit to such laudable agendas said Professor Salako.

The forthcoming third GET conference on bio-security scheduled to hold later in the year in Sierra Leone may be one of the many gateways to promote South-South collaborative research in West Africa.

Folayan is of New HIV Vaccine and Microbicide Advocacy Society

HIV and AIDS activism in Africa

HIV and AIDS activism in Africa

A Treatment Action Campaign Protest

 

By Morenike Oluwatoyin Folayan and Morolake Odetoyinbo

At the just-concluded 2018 Partners Forum that held from February 13 -15, 2018 at the Crowne Plaza, Johannesburg, South Africa, participants were taken through an Advocacy 001 class. The lecture sounded very much like what advocacy should be – planned, with timelines and targets, adequately funded with measureable targets. Sadly, the history of HIV and AIDS activism in Africa was not such structured campaigns.

HIV and AIDS activism evolved out of a desperate need to save lives. Usually, activists were challenging the draconic actions of big corporations and their own governments. A good case study for AIDS activism in Africa is the Treatment Action Campaign (TAC) in South Africa.

TAC sued and forced the South African government to roll out Nevirapine to prevent mother to child HIV transmission. In 2001, TAC supported the government against Pharmaceutical Manufacturers Association to preserve the Medicines Act of 1997. One year later, there was the campaign for civil disobedience to force treatment roll out for all people with HIV.

TAC’s actions were not spurred by approved proposals, or influenced by donor funding!

Communities were educated, local resources galvanized, and alliances formed with health care providers, religious leaders, trade unions and other civil society groups. TAC’s actions succeeded due to the social power they mustered; they did not mobilize because they had access to grants and foreign funded action plans.

TAC’s decision-making and action planning happened in the field; protests, matches, and pressure forming actions were taken. Journalists wrote reports, financial support followed their successful fights, the world heard about them, but more importantly, the South African government listened.

The movement for antiretroviral access in Nigeria also had a similar history.

People living with HIV took their fate in their hands. Without grants, foreign donations, the time to write proposals or skills to draw charts, the people coalesced to put pressure on the government to ensure access of antiretroviral drugs for Nigerians.

Nigerian AIDS activists taught journalists, doctors and community members the advocacy skills they learned from sister campaigns. A few quiet pioneers searched for, and modestly supported activists before the advent of big money like PEPFAR and the Global Fund. Nigerian activists seized a most critical time in history to take action – the 2005 International Conference on AIDS and STI in Africa (ICASA) which held in Abuja.

There was a movement in 2004/2005 by civil society organizations in Cambodia, Cameroon, Nigeria and Thailand, to end the conduct of a trial considered unethical by community members. The action started spontaneously – people identified a risk for their communities, they spoke up, and then mobilized themselves for action when their voices were not heard.

That movement led to the termination of the HIVprevention studies – the tenofovir trials – in Cambodia and Cameroon and a modification of the study implementation in Thailand. There were no grants to fund the movement. There are multiple other histories of HIV and AIDS activism in Africa – small, medium and big movements – that have led to landmark changes in HIV response. These activisms have pushed for recognition of the rights of individuals, populations and citizens. The victories won were the satisfactions gained by activists.

As young activists now receive classroom training on how to design, plan, implement and monitor activism with timelines, we hope the heat and heart is preserved. As they access large grants and funding for proposal writing, may we remember to teach them that activism is not run by grants, but by people.

Engaging, educating, mobilizing, and empowering people to challenge their governments, donors, allies and funders is the secret to the AIDS activism that brought change in Africa. Activism requires twenty percent money and one hundred percent angry and passionate people to disrupt unstructured governance systems on the continent.

HIV and AIDS activism for change in Africa depends on garnishing people power and not money power. It results from a collective belief in the good the population will receive because of our communitarian nature as Africans. We are organically driven, we evolve organically and our financial resources for action are marshaled on the field as our movements evolve. We often lack resources, but our movements do not die because they lack resources. Actions die in Africa when the people power is lost.

Folayan is of New HIV Vaccine and Microbicide Advocacy Society (NHVMAS)

Odetoyinbo is of Positive Action for Treatment Access (PATA).

No dicks in the Ring: A few experiences about the microbicide ring study  – Morenike Ukpong

No dicks in the Ring: A few experiences about the microbicide ring study  – Morenike Ukpong

By Morenike Oluwatoyin Folayan

At the 2018 Partners Forum held on the 13th to 15th of February, 2018 at the Crowne Plaza, Johannesburg, South Africa, Lisa Rossi of the Microbicide Trials Network and Leonard Solai of the International Partnership for Microbicides led a session discussing about the microbicide ring study with participants.

The Microbicide Trials Network and the International Partnership for Microbicides led studies to assess if the use of an antiretroviral named Dapivarine (a product not available for oral use) placed into a flexible ring found compatible with the vagina, and inserted and left into the vagina for one month, will reduce the risk of acquiring HIV infection through sexual intercourse. Dapivarine is slowly released from the flexible into the vagina over the course of a month.

Leonard explained that the study on the efficacy of the microbicide showed that women who were provided with the ring containing Dapivarine have a 30% lower risk of HIV infection than those who received a ring that did not contain Dapivarine. Further data analysis showed that women who used the product consistently throughout the study period had a 75% lower risk of HIV infection. Also the product was more effective in women older than 21 years.

‘Modeling studies show that microbicides like the dapivirine ring would be cost-effective and have a significant public health impact as part of a broader toolkit that could avert tens of millions of HIV infections over time in regions with high HIV infection like Southern Africa’ Leonard notes.

Lisa noted that a lot of follow up studies are being conducted to understand a lot more about the attitude of past study participants about the use of the ring for HIV prevention; to learn more about the safety and acceptability of the ring in young women and adolescents; to learn about its safety when used by pregnant and breastfeeding women; and to learn more about the safety and effectiveness of the ring when used for three months, or when it is used for both HIV and prevention of unwanted pregnancies.

YOU MAY ALSO LIKE: Valentine’s Day: Share love, not AIDS, NACA tells Nigerians

Participants at the meeting asked multiple questions about the ring one of which was the potential for men having vaginal sex with a woman using the ring to have the ring displaced by the penis. Lisa responded noting that there has been only one of such report during the study trial. However, for most part, no penis will get to touch the ring as it is located very high up in the vagina away from contact with the penis when having sexual intercourse. ‘So really, no dick in the ring’ says Manju Chatani-Gada.

People were curious about the possibility for reactions from the use of the ring, interactions with contraception, challenges with the insertion of the ring because of its size, possibility of use of the ring for anal sex, and possible associated challenges with use of the ring for partners who practice oral sex. From the responses to the questions by Liza and Leonard, it seems the ring is quiet safe with lots of potential for use for topical application of microbicide for women.

Applications for regulatory approval for public access to the rings in Southern and Eastern Africa are ongoing. Regulatory approval of the ring by the FDA of the United States will increase the prospect of the ring being accessible through PEPFAR-funded projects in Africa. Hopefully, then, women in West and Central Africa may also have access to the product.

Folayan is of the New HIV Vaccine and Microbicide Advocacy Society.

“Funding is not all it takes to do good research” – Ogunsola

“Funding is not all it takes to do good research” – Ogunsola

Prof. Folasade Ogunsola

 

By Morenike Oluwatoyin Folayan.

Professor Folasade Ogunsola, the Deputy Vice-Chancellor, Development Services, University of Lagos, and one of Nigeria’s leading researchers, has said that funding is not all it takes to be a good researcher.

Ogunsola spoke during the just concluded 5th Nigeria Global Health Trials Conference which held between January 30 and 31st, at the Sickle Cell Foundation Centre, Idi-Araba, Surulere, Lagos and attracted over 250 participants comprising doctors, medical researchers and scientists from within and outside the country.

During her presentation titled ‘Health research and global health: Potentials and Promises of North-South Collaboration,’ Professor Ogunsola shared her experience concerning how she grew up the ladder to become an equitable partner with her Northern collaborators.

She also highlighted the importance of passion for the work you do, as well as trust being an essential ingredient for sustainable collaboration and partnership.

Professor Ogunsola further reiterated her point by sharing the story of the ninth graders who conducted some research based on awareness of events happening to them. Their extremely low cost experiment is now drawing the attention of renowned scientists to further explore their findings.

“Research requires you to be conscious about what is happening around you, develop evidence to substantiate your assumptions and looking for solutions applicable to your environment. Without the passion and the eye to address local needs, the funds will often not be put to efficient use,” she noted.

YOU MAY ALSO LIKE: Why social disruption is needed for the research enterprise in Nigeria

Participants identified the need to ensure subsequent meetings have policy makers attend the meetings. They also get to interact and learn. This was a missing target population at the conference. For future conferences, it was agreed that this should be rectified.

The role of effective communication, need to ensure research results are disseminated beyond the use of journal publication and the role of the media in disseminating research results were also noted.

The conference came to an end with participants feeling extremely motivated to do things differently. Hopefully, new networks, partnerships and collaborations had been formed at the end of the two-day meeting.

Folayan is of the New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) Nigeria

Should researchers be trained on health politics? – Morenike Ukpong

Should researchers be trained on health politics? – Morenike Ukpong

African researchers at work

By Morenike Oluwatoyin Folayan

At the venue of the ongoing training on Protection of human research participants and responsible conduct of research organized by the National Health Research Ethics Committee for 15 researchers of the MGIC, Abuja, Professor Kola Oyedeji of the University of Lagos identified the need for researchers to be trained on health politics.

Professor Oyedeji identified that one of the reasons for this assertion is that the implementation of research findings needs extensive political engagement as some of the research findings do not appeal to policy makers and politicians. Researchers need to learn how to translate these research findings in ways that makes sense for use by politicians and policy makers.

This implies that researchers also have to learn the language of politicians to enable them translate research findings for use for the purpose of benefiting researched communities.

Secondly, political terms and tenures have implications for research funding and research implementation timelines. Nationally commissioned studies are often required to be implemented during the tenure of political officers so that they can report positive research findings as part of the deliverables of their governance.

This is very clear with the events that have happened with the cut back of research funding in the United States during the Trump administration. In Nigeria, top PEPFAR funded research institutions are equally being pressured to complete the planned HIV Indicator survey, proposed to be implemented over a 3 year period, by 2018 so that the results of the survey can be announced before the elections in 2019. It is anticipated that the survey will show that the HIV prevalence and incidence has dropped significantly in Nigeria.

Participants at the 3-day training (16th – 18th January 2018) organized by the Bioethics Society of Nigeria which held at the training room of the MGIC Nigeria office, identified with the need for extensive engagement of stakeholders through the planning, implementation and dissemination phases of research.

They noted this has been the norm of their research practice as most often, stakeholders engaged in discussions about their research protocols often give inputs to their research protocols prior to protocol submission for ethics approval.

Mr Godwin Brooks of the Federal Ministry of Health shared with participants the implications of researchers’ non-engagement of stakeholders, including policy makers at the time of the research design through to its implementation. Often, when policy makers are invited to listen to research results, the risk is that policy makers do not adopt the research findings because they query the methodology, query the research findings and do not identify with the research result.

While appreciating the need for stakeholder engagement at the research conceptualization stage, participants identified that this may be extremely challenging for international research many other international partners are engaged with. Some of their protocols had been designed prior to their engagement as Southern partners. They are also often under pressure from the Northern partners to deliver results within specified timelines.

Professor Oyedeji noted that things can change. Things need to change if we want to see improvement in the health care systems in Nigeria. Community members are becoming more research literate, and will become more demanding for accountability from researchers as the years roll bye.

Researchers need to become proactive in their relationships with stakeholders. One of the areas change needs to happen is their active engagement of stakeholders with research design and implementation.

As trained Health Politicians, researchers will be able to negotiate the political landmines, ensure the public benefits from the research outcomes, and facilitate political will for continued investment in research.

Folayan is Co-Coordinator of New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) Nigeria.